SCHEMBL21757618

SCHEMBL21757618

O=CNc1ccc(OCCCCCN2CCOCC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.59
▸ EPHX2 P34913 5/20 0.57
▸ HRH3 Q9Y5N1 3/20 0.57
▸ MAPK1 P28482 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ CHRM2 P08172 1/20 0.57
▸ CHRM1 P11229 1/20 0.57
▸ HTR2A P28223 1/20 0.57
▸ SCN1A P35498 1/20 0.57
▸ HTR2B P41595 1/20 0.57
▸ KCNH2 Q12809 1/20 0.57
▸ SCN2A Q99250 1/20 0.57
▸ SIGMAR1 Q99720 1/20 0.57
▸ SCN3A Q9NY46 1/20 0.57
▸ MEN1 O00255 1/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ KMT2A Q03164 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21757629 0.99 HRH3 (0.58) KDM4ESMN1; SMN2EPHX2HRH3MAPK1
SCHEMBL21757567 0.95 HRH3 (0.63) EPHX2HRH3MAPK1ALDH1A1CYP1A2
SCHEMBL14368318 0.91 CA12 (0.58) KDM4ESMN1; SMN2EPHX2HRH3MAPK1
SCHEMBL21276708 0.89 HRH3 (0.59) EPHX2HRH3MAPK1ALDH1A1CYP1A2
SCHEMBL21757596 0.89 TSHR (0.66) KDM4ESMN1; SMN2EPHX2HRH3MAPK1
SCHEMBL21757528 0.85 HRH3 (0.62) HRH3KCNH2MEN1KMT2ALMNA
SCHEMBL17296202 0.81 HRH3 (0.62) KDM4ESMN1; SMN2HRH3MAPK1ALDH1A1
SCHEMBL21276824 0.79 HRH3 (0.51) EPHX2HRH3MAPK1ALDH1A1CYP1A2
SCHEMBL21276814 0.79 EPHX2 (0.51) KDM4EEPHX2HRH3MAPK1ALDH1A1
SCHEMBL21276719 0.79 HRH3 (0.48) EPHX2HRH3MAPK1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215509-B1 SUBSTITUTED PYRROLO[1,2-A]PYRIMIDINES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS LYSOSOMAL THERAPEUTICS INC (US) 2020-02-26 — — EP disclosed
Send feedback